EU MDR and Device Regulations Explained: Complete Guide for Pharma, Compliance, and Market Access EU MDR and Device Regulations: Strategic Guide for Regulatory Affairs Professionals Introduction to EU MDR and Device Regulations The European Union Medical Device Regulation (EU MDR 2017/745) came into effect in May 2021, replacing the Medical Device Directive (MDD). This regulation introduced significant changes to the regulatory landscape for medical devices in the EU, impacting not only device manufacturers but also pharmaceutical companies developing drug-device combinations. The European Medicines Agency (EMA) plays a critical role in overseeing drug-device integration, while notified bodies ensure compliance for device…

Introduction to EU MDR for Drug-Device Combinations Introduction to EU MDR for Drug-Device Combinations The regulation of drug-device combinations in the European Union is increasingly complex, particularly with the implementation of the EU Medical Device Regulation (EU MDR). This step-by-step guide aims to provide regulatory affairs professionals with a comprehensive overview of the EU MDR framework relevant to drug-device combinations, including steps for compliance, documentation requirements, and practical actions to navigate this regulatory landscape. This guide emphasizes EU MDR consulting services and highlights key considerations for industry stakeholders. Step 1: Understanding the Regulatory Framework of EU MDR The first step…

When Is a Drug Considered a Medical Device in the EU? When Is a Drug Considered a Medical Device in the EU? This comprehensive guide provides actionable insights into the intricate regulatory boundaries that define when a drug is considered a medical device under EU regulations. With a focus on the implications for regulatory affairs professionals, this tutorial outlines clear steps for navigating the EU MDR, specifically for those involved in companion diagnostic regulatory consulting. Step 1: Understanding the Definitions Under EU Regulations The first step in determining whether a drug qualifies as a medical device in the EU involves…

Role of Article 117 in EU MDR for Combination Products Role of Article 117 in EU MDR for Combination Products The European Union Medical Device Regulation (EU MDR) introduced several significant changes to the regulatory framework overseeing combination products. Article 117 plays a pivotal role in this change, particularly in guiding how medicinal products that incorporate devices are regulated. This guide aims to walk stakeholders through the essential steps required for understanding and implementing Article 117 effectively. As the regulatory landscape evolves, it is crucial for professionals involved in regulatory affairs, quality assurance, and clinical operations to fully grasp these…

Device Technical Documentation Requirements Under MDR Annex II Device Technical Documentation Requirements Under MDR Annex II Understanding and fulfilling the technical documentation requirements under the EU Medical Device Regulation (MDR) Annex II is critical for manufacturers of medical devices and combination products. This guide provides a systematic approach to ensuring compliance, particularly important for companies also navigating the FDA combination product consulting landscape. By utilizing the steps outlined below, you will gain a comprehensive understanding of the documentation expectations and preparation process required for regulatory approval in the EU market. Step 1: Understand the Scope and Purpose of Annex II…

Classification and Risk Rules Under MDR (Annex VIII) for Combined Use Classification and Risk Rules Under MDR (Annex VIII) for Combined Use The European Union Medical Device Regulation (EU MDR) establishes specific guidelines for the classification and management of combination products, particularly in regard to Annex VIII. This tutorial serves as a comprehensive guide for regulatory affairs professionals involved in FDA combination product consulting, highlighting the necessary steps for compliance with both EU regulations and requirements as stipulated under the EU MDR. This article will detail the classifications, risk assessment processes, and essential documentation required at each stage. Understanding the…

Notified Body Involvement in Drug-Device Combinations Under MDR Notified Body Involvement in Drug-Device Combinations Under MDR The intersection of medical devices and pharmaceuticals presents unique regulatory challenges, particularly under the European Medical Device Regulation (EU MDR). For drug-device combinations, understanding the role of the Notified Body is critical for compliance and market access. This guide provides a structured approach to navigate the regulatory landscape, focusing on the key steps required for ensuring appropriate Notified Body involvement in these product categories. Step 1: Understanding the Regulatory Framework for Drug-Device Combinations Drug-device combinations are products that combine a pharmaceutical component with a…

How to Prepare a Notified Body Opinion (NBOp) for Article 117 How to Prepare a Notified Body Opinion (NBOp) for Article 117 The transition toward the new regulations under the EU Medical Device Regulation (EU MDR) emphasizes robust regulatory processes, particularly for combination products that incorporate medicinal products. Article 117 stipulates the need for a Notified Body Opinion (NBOp) for such products. This comprehensive guide aims to provide U.S.-based regulatory affairs professionals with a step-by-step approach for the preparation of a Notified Body Opinion, tailored specifically to comply with the regulatory expectations under EU MDR. Step 1: Understanding the Framework…

MDR Conformity Assessment Process for Device–Drug Combinations MDR Conformity Assessment Process for Device–Drug Combinations The regulation of device–drug combinations in the European Union is governed under the Medical Device Regulation (MDR), specifically relevant to the evaluation pathways and requirements of such products. This guide serves as a comprehensive tutorial for professionals involved in ensurings compliance with the MDR, highlighting critical phases and actions necessary for successful navigation through the conformity assessment process. This US-focused guide provides actionable insights and documentation expectations to uphold both regulatory and operational excellence. Step 1: Understand the Regulatory Framework The first step in the MDR…

UDI Requirements for Device Components of Combination Products UDI Requirements for Device Components of Combination Products The regulatory landscape for combination products in the United States, particularly concerning Unique Device Identification (UDI) requirements for device components, is complex. Understanding these requirements is vital for compliance in product development and market entry. This guide presents a systematic approach for navigating the UDI requirements under both FDA regulations and EU MDR, ensuring that regulatory affairs professionals are equipped with practical insights. Step 1: Understanding Combination Products Combination products are therapeutic and diagnostic products that combine drugs, devices, and/or biological products. The FDA…